Breast Cancer Month: what’s new in cancer research?

The Breast Cancer Awareness Month wants to raise awareness about the disease among women across the world every October. BREAST CANCER STATISTICS The female breast cancer is the second leading cause of cancer death (11.6%), following lung cancer mortality which is 18.4% of the total cancer deaths according to GLOBOCAN 2018 estimates of cancer mortality […]

Target2cure: a new collaboration project for First Health Pharmaceuticals

In its continuous efforts to improve and develop HIV treatments and cure strategies, First Health Pharmaceuticals is pleased to announce its participation in a new multi-center public-private partnership called Target2Cure, starting September 2019 and lasting three years. Target2Cure consortium includes six high profile research groups from AUMC- Amsterdam University Medical Centre and four industrial partners […]

First Health Pharmaceuticals congratulates NMAC on the 2019 USCA and Paul Kawata’s 30th anniversary as Executive Director

First Health Pharmaceuticals congratulates National Minority AIDS Council (NMAC) on a successful 2019 US Conference on AIDS (USCA). The USCA has historically served as the premier national conference that facilitates the intersections of community involvement and the federal treatment and research process, bringing together representatives focused on policy development, science and advocacy from around the […]

Our collaboration group from University of Milan attends ESCCA2019

First Heath Pharmaceuticals is thrilled to announce the participation at the European Society for Clinical Cell Analysis, ESCCA 2019, of one of its major collaboration groups, the academic research team of the University of Milan at Humanitas Clinical and Research Center of Rozzano (Milan). ESCCA is a scientific society founded to promote and improve the […]

First Health Pharmaceuticals at USCA2019

First Health Pharmaceuticals will participate at the 2019 United States Conference on AIDS – USCA2019 that will be held from Sep 05 – 08, 2019 at Marriott Marquis Washington, DC. USCA is organized by the National Minority AIDS Council (NMAC). NMAC hopes to normalize the discussion on race issues in the HIV movement. NMAC wants […]

First Health Pharma to collaborate with Oncode Institute

First Health Pharmaceuticals is thrilled to announce its latest collaboration on cancer research with an Oncode Institute-affiliate. Oncode is an independent Dutch research institute established in 2018. It brings together 62 prominent cancer research leaders from twelve established partner institutes. Like First Health Pharmaceuticals, Oncode Institute focuses on guiding advanced molecular oncology towards translational and […]

Can we speed along HIV treatment with lower toxicity?

When it comes to the latest news on HIV treatment, there are some very hopeful research results about newly developed drugs and therapies, but most of them have significant side effects and toxicities in long-term use. Plus magazine‘s contributor Jeannie Wraight, on her latest article about HIV treatment, focused on the importance of prioritizing therapeutics based on […]

Our HIV cure research on A&U Magazine

On December 2018, one of the most important american HIV/AIDS magazines, A&U – America’s AIDS Magazine, wrote about the new HIV cure research strategies. The article written by columnist Jeannie Wraight, pointed out the need for a not only efficacious but also affordable HIV cure, introducing consequently First Health Pharmaceuticals‘ cutting edge antiretroviral research that […]

Care and Take Care – HIV/AIDS awareness campaign

Today on World AIDS Day we announce the official start of our Care and Take Care – HIV/AIDS awareness program, which specifically targets adolescents worldwide through our social media campaign #kissaidsgoodbye. #kissaidsgoodbye wants to spread a positive message: “Care and Take Care”; protect yourself and protect the ones you love. It is also a message […]

New HIV/AIDS projects from First Health United

On World AIDS Day, First Health United is proud to announce two important HIV/AIDS projects. Unfortunately, HIV and AIDS still are a substantial problem in several developing countries. Problems with late diagnosis and poor adherence to ART medication often still leads to AIDS related co-morbidities of HIV. In collaboration with First Health Pharmaceuticals, First Health United […]

October, Breast Cancer Awareness Month

Breast cancer awareness month is a worldwide annual campaign that involves several organisations all around the world to help raise awareness about breast cancer through education on symptoms, early detection and treatment as well. According to GLOBOCAN, breast cancer is the most commonly occurring cancer in women, accounting for 25.1% of all cancers and the […]

Is HIV really under control?

The official lecture is that since the advent of ARV combination therapies to keep HIV under control, by now twenty years ago, AIDS disappeared and made place for a no longer life threatening but lifelong “HIV management”. The general idea is that HAART regimens are efficient and relatively comfortable for the patients and the main […]

First Health supports LGBTQI rights and equality

First Health Pharmaceuticals B.V. has been openly championing LGBTQI rights since its foundation. We reaffirm our commitment against all forms of discrimination by supporting Pride Amsterdam 2018 taking place this week hard on the heels of AIDS2018 International Conference where First Health participated as an exhibitor and which theme was ‘Breaking Barriers Building Bridges’, with […]

First Health to participate at AIDS2018 Conference

First Health Pharmaceuticals and First Health United Foundation are going to participate at AIDS2018, the 22nd International AIDS Conference on HIV and AIDS, which will take place in RAI Amsterdam Convention Centre of Amsterdam, the Netherlands, from 23 to 27 July 2018. First Health Pharmaceuticals, since its foundation in 2015, has addressed its field of research […]

“Everybody Counts” – World AIDS Day 2017

Global HIV & AIDS figures According to the latest global statistics on the status of AIDS epidemic, in 2016, 36.7 million people were living with HIV: 1.8 million people became newly infected and 1 million people died from AIDS-related illnesses. As of June 2017, 20.9 million people living with HIV were accessing antiretroviral therapy (ART), which […]

Preparing for AIDS2018

The biennial International AIDS Conference, AIDS2018, is the world’s biggest healthcare conference and will be held in Amsterdam from July 23rd to 27th, 2018. Over 20.000 healthcare professionals as well as people living with HIV and International media are expected to participate in this event. For one week, the eyes of the world will be focused on Amsterdam and the […]

Advancements in protein-ligand analysis significantly speed up development

NanoDSF and MicroScaleThermophoresis (MST) are two groundbreaking technologies concerning protein-ligand binding assay offered by our development partner Proteros GMBH. Used in conjunction, these technologies offer a cost-effective and rapid high-throughput alternative for traditional fluorimetric protein-ligand binding assays. By means of nanoDSF, hundreds of compounds can be rapidly screened and selected for protein binding affinity, after which MicroScaleThermophoresis […]

Tropical Virus targets transferred to non-profit organization First Health United

Today the final agreement was signed through which biotech company First Health Pharmaceuticals transferred large part of its pipeline of highly active antivirus agents concerning Tropical virus targets to the independent non-profit First Health United Foundation. The signing of the agreement was the crowning event after a long period of preparations that resulted in the […]

Efficient results against metastatic Prostate-, Lung- and Breast Cancer

The latest results of a wide range of cell culture assays of some of our compounds against triple negative metastatic breast cancer, metastatic (smokers) lung cancer and metastatic prostate cancer have demonstrated excellent activity, ranging from nanomolar to sub-micromolar inhibitory concentrations. Additional tests are currently prepared that will expand the investigation to several other important […]

New discoveries about the role of DDX3 in Cancer

Our research clearly points towards an important role of DDX3 overexpression in cancer. We have already had very positive test results in breast cancer but we are also investigating most specific targets such as “smokers” Lung cancer and advanced Prostate cancer. We have further strengthened our investigations into these targets and now we are working […]

First Health Pandemics Taskforce

The DDX3 RNA Helicase is a known host factor for a wide array of viruses of which many are already investigated by our group. Some of these viruses, such as HIV and HCV, are widespread around the world while many others like Dengue or Zika are of more specific importance to developing countries. A specific […]

World AIDS Day 2016

World AIDS Day 2016 – December 1 Substantial progress is being made, but more than half of all HIV patients are still untreated. According to the World Health Organisation, the number of people living with HIV continues to increase in large part, because more people globally are accessing antiretroviral therapy and as a result, are […]

Three Important new Viral Disease related Research Projects started

Besides investigating and optimising the efficacy, toxicity and deliverability of our antiviral compounds, we also started three closely related research projects. One focuses on the possibilities of a Cytokine Storm mitigating effect of our compounds in Ebola and severe Dengue. The other project concentrates on the possibility of an application of our compounds in a […]